Jonathan Jay Mazelsky, President and CEO at IDEXX LABORATORIES INC /DE (IDXX), sold 58,520 shares at $626.90 ($37.0M) on 2025-08-06, disclosed to the SEC on 2025-08-08.
Seasonal sale ($37.0M) by President and CEO — this insider has traded IDXX in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $626.90 | 1,095 | $686K | 1.9% |
| 2 | $626.90 | 1,095 | $686K | 1.9% |
| 3 | $628.27 | 1,525 | $958K | 2.6% |
| 4 | $628.27 | 1,525 | $958K | 2.6% |
| 5 | $629.82 | 3,397 | $2.1M | 5.8% |
| 6 | $629.82 | 3,397 |
| $2.1M |
| 5.8% |
| 7 | $630.59 | 6,056 | $3.8M | 10.3% |
| 8 | $630.59 | 6,056 | $3.8M | 10.3% |
| 9 | $631.61 | 7,299 | $4.6M | 12.5% |
| 10 | $631.61 | 7,299 | $4.6M | 12.5% |
| 11 | $632.56 | 3,000 | $1.9M | 5.1% |
| 12 | $632.56 | 3,000 | $1.9M | 5.1% |
| 13 | $635.13 | 3,526 | $2.2M | 6.1% |
| 14 | $635.13 | 3,526 | $2.2M | 6.1% |
| 15 | $636.15 | 1,822 | $1.2M | 3.1% |
| 16 | $636.15 | 1,822 | $1.2M | 3.1% |
| 17 | $636.81 | 880 | $560K | 1.5% |
| 18 | $636.81 | 880 | $560K | 1.5% |
| 19 | $639.37 | 660 | $422K | 1.1% |
| 20 | $639.37 | 660 | $422K | 1.1% |
| Total | $631.98 avg | 58,520 | $37.0M | 100% |
| Filing → |
| IDXX | SELL | 2023-12-06 | $7.3M | — | Filing → |
| IDXX | SELL | 2023-09-05 | $13.7M | — | Filing → |
| IDXX | SELL | 2022-11-16 | $8.9M | — | Filing → |